Quarterly report pursuant to Section 13 or 15(d)

Accounts Payable and Accrued Liabilities and Compensation (Details)

v3.23.4
Accounts Payable and Accrued Liabilities and Compensation (Details)
$ in Thousands
6 Months Ended 12 Months Ended
Nov. 30, 2023
USD ($)
item
May 31, 2023
USD ($)
item
Accounts Payable and Accrued Liabilities and Compensation    
Accounts payable $ 62,328 $ 62,725
Number of vendors | item 2 2
Compensation and related expense $ 228 $ 335
Legal fees and settlement 81 168
Clinical expense 346 187
Accrued inventory charges and expenses 7,023 4,978
License fees 1,330 862
Lease payable 142 139
Total accrued liabilities $ 9,150 $ 6,669
Accounts Payable | Credit Availability Concentration Risk | Vendor One    
Accounts Payable and Accrued Liabilities and Compensation    
Concentration risk, percentage 70.00%  
Accounts Payable | Credit Availability Concentration Risk | Vendor Two    
Accounts Payable and Accrued Liabilities and Compensation    
Concentration risk, percentage   72.00%